Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myeloid-Derived Suppressor Cell Differentiation Pathway (None)
- Target
- None
- Molecular classification
- Signaling pathway, Transcription factor network, Cytokine signaling
01
Overview
The myeloid-derived suppressor cell (MDSC) differentiation pathway refers to the molecular and cellular processes by which immature myeloid cells develop into MDSCs, a heterogeneous population of immunosuppressive cells. These cells are primarily generated from myeloid precursors in the bone marrow under pathological conditions such as cancer, chronic inflammation, infection, trauma, and autoimmune diseases. Key regulators include STAT3, C/EBPβ, and c-Rel. MDSCs play a central role in suppressing adaptive immune responses and contribute to tumor progression. Targeting this pathway is an active area for novel anti-cancer therapies.
02
Mechanism of action
Inhibition of MDSC differentiation, promotion of MDSC terminal differentiation, blockade of MDSC recruitment, depletion of MDSCs.
03
Biological functions
Immune suppressionMyelopoiesis regulationCell differentiationTumor microenvironment modulation
04
Disease associations
Cancer progressionMetastasisChronic inflammationInfectionAutoimmune diseases
05
Safety considerations
Potential for broad immunosuppressionOff-target effects on other myeloid cell populationsDevelopment of resistanceCytokine release syndrome
06
Interacting drugs
Monoclonal antibodies against MDSC surface markers
5 more in the full profile.
07
Biomarkers
CD11bGr-1Ly6GLy6CCD33HLA-DRArginase activityNitric oxide (NO) productionReactive oxygen species (ROS) generationS100A8/A9 levels
Beyond the preview
Go deeper on Myeloid-Derived Suppressor Cell Differentiation Pathway (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myeloid-Derived Suppressor Cell Differentiation Pathway (None).